22438257 |
Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ
Bauer, R,
Godfrey, R,
Müller, JP,
Schnetzke, U,
Dagnell, M,
Böhmer, SA,
Heinrich, T,
Böhmer, FD,
Arora, D,
Stopp, S,
Östman, A,
Scholl, S
|
Blood |
2012 |
26308771 |
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells
Valent, P,
Frey, S,
Böhmer, SA,
Fischer, T,
Schröder, K,
Serve, H,
Heidel, FH,
Sperr, WR,
Lässig, J,
Moriggl, R,
Böhmer, FD,
Barth, J,
Berg, T,
Bauer, R,
Jayavelu, AK,
Müller, JP,
Cerny-Reiterer, S,
Maurer, B,
Scholl, S,
Oellerich, T,
Shah, AM,
Fischer, M
|
Leukemia |
2016 |
18192505 |
Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
Sallmyr, A,
Grosu, D,
Rassool, F,
Small, D,
Shapiro, P,
Datta, K,
Fan, J,
Kim, KT
|
Blood |
2008 |
21262971 |
Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling
Bauer, R,
Godfrey, R,
Masson, K,
Müller, JP,
Schons, J,
Böhmer, SA,
Tänzer, S,
Razumovskaya, E,
Böhmer, FD,
Arora, D,
Stopp, S,
Rönnstrand, L
|
J. Biol. Chem. |
2011 |
29880609 |
Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia
Schnöder, TM,
Bauer, R,
Serve, H,
König, R,
Müller, JP,
Ast, V,
Böhmer, FD,
Kresinsky, A,
Meyer, D,
Heidel, FH,
Berg, T
|
Haematologica |
2018 |